Cyano-hydroxyimino-acetic acid ethyl ester (Oxyma)

Cyano-hydroxyimino-acetic acid ethyl ester (Oxyma) is a small-molecule amino acid coupling reagent featuring a cyano-substituted hydroxyimino moiety and an ethyl ester functional group. The hydroxyimino functionality can engage in acyl transfer chemistry commonly used to suppress side reactions during peptide bond formation, while the cyano group tunes electrophilicity and stabilizes reactive intermediates. As a chiral-independent coupling additive with strong carbonyl-reactive behavior, Oxyma is typically handled as a defined reagent rather than a stereogenic building block, yet it directly influences the stereochemical outcome of the peptide synthesis environment by improving coupling efficiency and reducing racemization. The ester group and oxime-like oxygen enable downstream conversion into acyl-activated species and support compatibility with standard protected amino acid strategies and peptide coupling workflows.

1. Peptide Coupling Chemistry

Cyano-hydroxyimino-acetic acid ethyl ester (Oxyma) is applied in peptide synthesis workflows as a coupling additive that modulates the formation and reactivity of activated carboxylic acid intermediates. The cyano-hydroxyimino motif can participate in transient ester-to-amide conversion pathways, while the ethyl ester and oxime-like oxygen functionality support controlled acyl activation under common peptide coupling conditions. Protected amino acids bearing N-protecting groups and C-terminal carboxyl functions can be coupled with reduced formation of undesired byproducts that arise from poorly controlled activation. Downstream, Oxyma-enabled coupling supports preparation of protected peptide fragments, longer peptide sequences, and peptide analog libraries used in biochemical research and synthetic methodology development.

2. Racemization Control

Cyano-hydroxyimino-acetic acid ethyl ester (Oxyma) functions in stereochemical quality management for protected amino acid chemistry by influencing the lifetime and reactivity of acyl-activated species. The hydroxyimino functionality is structurally suited to regulate pathways that can lead to epimerization at the alpha stereocenter of amino acid substrates during amide bond formation. The presence of the cyano group helps tune reactivity, which can be leveraged when coupling sterically hindered residues or when using amino acid derivatives with labile stereocenters. Resulting peptide products can be used for structure-activity relationship studies, stereochemically defined peptidomimetics, and analytical investigations where epimeric impurities must be minimized.

3. Protected Amino Acid Synthesis

Cyano-hydroxyimino-acetic acid ethyl ester (Oxyma) can be employed in synthetic organic chemistry to support peptide building block preparation from protected amino acids and their carboxyl-activated derivatives. The reagent's ability to participate in acyl activation is relevant to processes where N-protected amino acids are converted into amide-linked intermediates without extensive modification of the amino acid protecting-group scheme. The ethyl ester component and oxime-like oxygen enable formation of reactive intermediates that can be directed toward amide bond construction, supporting iterative synthesis of protected peptide fragments. Industrially, such coupling-compatible intermediates are useful for fine chemical synthesis routes that require reproducible peptide bond formation while maintaining protecting-group integrity.

4. Peptidomimetic And SAR Libraries

Cyano-hydroxyimino-acetic acid ethyl ester (Oxyma) is suitable for constructing peptidomimetic scaffolds and SAR-focused compound sets where rapid assembly of amide-rich structures is required. The coupling reagent's hydroxyimino and cyano functionalities are structurally aligned with acyl activation chemistry that supports efficient formation of peptide-like linkages between protected building blocks. Side-chain functional groups on amino acid derivatives, including those protected as esters, carbamates, or other orthogonally removable groups, can be preserved when coupling conditions are tuned to avoid excessive harshness. Downstream, Oxyma-assisted synthesis supports generation of analog series for molecular design studies, including fragment elaboration and structure-guided optimization campaigns.

5. Pharmaceutical Manufacturing Intermediates

Cyano-hydroxyimino-acetic acid ethyl ester (Oxyma) can be integrated into industrial peptide and peptide-analog manufacturing workflows as a process-relevant coupling additive for controlled amide bond formation. The reagent's defined functional groups enable it to act at the stage of carboxylic acid activation, aligning with manufacturing needs for consistent conversion of protected amino acid substrates into peptide intermediates. The cyano-hydroxyimino system can help reduce formation of coupling-related side products that complicate purification of manufacturing intermediates. Downstream, Oxyma-compatible coupling supports scalable preparation of protected peptide segments, process development for peptide synthesis, and specialty chemical production of amino acid-derived intermediates used in applied chemical manufacturing contexts.

6. Analytical Standards And Method Development

Cyano-hydroxyimino-acetic acid ethyl ester (Oxyma) is used in analytical research contexts to support method development for monitoring peptide coupling reactions and for characterizing acyl-activation behavior. The reagent's distinct cyano-hydroxyimino and ester functionalities provide identifiable chemical signatures that can be tracked by chromatographic and spectrometric methods during peptide synthesis optimization. The ability to influence activated intermediate profiles makes it relevant for studying reaction completeness, impurity formation patterns, and coupling-related byproducts that affect peptide quality. Downstream, Oxyma-informed analytical workflows can be applied to quality-by-design investigations for amino acid derivative synthesis and to stereochemical impurity assessment in peptide building block production.

1. Emu oil in combination with other active ingredients for treating skin imperfections

2. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

3. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

4. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

5. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance